PMND1: John Lieske, M.D.

Answers from the Lab
16/08/2022 8 min Episodio 166
PMND1: John Lieske, M.D.

Listen "PMND1: John Lieske, M.D."

Descargar episodio Ver en sitio original

Episode Synopsis


(00:31)  Could you tell us a bit about yourself and your background?(01:11) Could you describe these new tests and when it would be appropriate to use each of them in the clinic?(03:16) Could you provide a little background on why MCL is making changes to the PLA2R test?(04:34) Could you describe the change to KDIGO guidelines and when it may be appropriate to skip the biopsy? How will these new tests help physicians implement these new guidelines in their practices?

More episodes of the podcast Answers from the Lab

Breakthroughs and Trends That Defined Lab Medicine in 2025 18/12/2025
Accelerating Research and Development With BioPharma Diagnostics 04/12/2025
Unlocking the Unknown With Metagenomics 20/11/2025
Forging Collaborations That Deliver Better Outcomes 06/11/2025
Advancing Precision Medicine Through Therapeutic Tests 23/10/2025
Developments for LDT Regulation and Laboratory Reimbursement: Bill Morice, M.D., Ph.D. 16/10/2025
Self-Collection Testing Expands to New Areas: Elitza Theel, Ph.D. 02/10/2025
Flesh-Eating Organisms Making the News: Bill Morice, M.D., Ph.D. 11/09/2025
Whole Exome Sequencing Reflex Test Offers Cost-Effective Diagnosis: Cherisse Marcou, Ph.D., and Kristen Rasmussen, M.S., CGC 02/09/2025
Rabbits, Chikungunya, and More Viral News: Matthew Binnicker, Ph.D. 28/08/2025
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA